Powered by Sanofi, a new BioMed X research team will develop a computational platform designed to accelerate drug development
BioMed X, a German independent...
BioMed X announced today the expansion of its collaboration with Boehringer Ingelheim with the launch of a new model for biomedical research: XSeed Labs....
After successfully completing a project in RNA splicing in cancer this January, BioMed X and Merck continue their oncology collaboration to explore tumor immunogenicity...